Beth Israel Deaconess Medical Center in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital and New England Deaconess Hospital.

There are 673 beds in Beth Israel Deaconess Medical Center/Harvard Medical School.

During the past decade, Beth Israel Deaconess Medical Center/Harvard Medical School conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center/Harvard Medical School" #1 sponsor was "Beth Israel Deaconess Medical Center" with 4 trials, followed by "Bolton Medical" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "University of California, Los Angeles" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center/Harvard Medical School" #1 collaborator was "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Canary Foundation" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Early Detection Research Network" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Beth Israel Deaconess Medical Center/Harvard Medical School" are "Colorectal Cancer" (3 trials), "Apoplexy" (2 trials), "Cerebrovascular Accident" (2 trials), "Psychosis" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Beth Israel Deaconess Medical Center/Harvard Medical School" in a lesser frequency.

Most popular intervention types in "Beth Israel Deaconess Medical Center/Harvard Medical School" are "Drug" (7 trials), "Device" (6 trials), "Behavioral" (5 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "12-week Education Program" (1 trials), "12-week Tai Chi Program" (1 trials), "Active Suction (Dig)" (1 trials) and "Active Suction (Trad)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beth Israel Deaconess Medical Center/Harvard Medical School" are 22 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Beth Israel Deaconess Medical Center/Harvard Medical School". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Beth Israel Deaconess Medical Center/Harvard Medical School, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beth Israel Deaconess Medical Center/Harvard Medical School, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".